Gut Robert

SEC Form 4 insider trading activity

Gut Robert has filed 3 SEC Form 4 filings (13 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Jun 12, 2026.

On the most recent filing, Gut Robert is listed as Director at uniQure N.V. Inside the rolling window, Gut Robert reported no open-market purchases and 4 open-market sales totaling $1.8M in QURE. The largest disclosed transaction in the window is a sale of 31,434 QURE shares on Nov 6, 2025, worth $857K.

Companies traded

Other insiders at QURE

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$1.8M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
QURESale$197KJun 12SEC ↗
QURESale$74KJun 12SEC ↗
QURESale$630KJan 14SEC ↗
QURESale$857KNov 10SEC ↗
Showing 1–4 of 4
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Gut Robert made?

Gut Robert has filed 3 SEC Form 4 filings (13 transaction rows) across 1 company since 2025.

Which companies does Gut Robert trade?

Gut Robert has filed SEC Form 4 disclosures for 1 company, including QURE.

When was Gut Robert's most recent SEC Form 4 filing?

Gut Robert's most recent SEC Form 4 filing on Tracefour is dated Jun 12, 2026.

What is Gut Robert's total buy and sell value in the current window?

Inside the rolling retention window, Gut Robert bought $0 and sold $1.8M based on SEC Form 4 filings.

What was Gut Robert's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 31,434 QURE shares on 2025-11-06, worth $857K, per SEC Form 4 filings.